what is a prostate-specific antigen test?

The blood level of what is prostate-specific antigen test is many times raised in individuals with prostate malignant growth, and the what is prostate-specific antigen blood test was initially endorsed by the FDA in 1986 to screen the movement of prostate malignant growth in men who had previously been determined to have the infection.

In 1994, FDA endorsed the PSA test to be utilized related to a computerized rectal test (DRE) to support the recognition of prostate malignant growth in men 50 years and more seasoned. Until around 2008, many specialists and expert associations had energized yearly PSA evaluation for prostate malignant growth starting at age 50.

Public service announcement testing (alongside a DRE) is additionally frequently involved by medical care suppliers for people who report prostate side effects to assist with deciding the idea of the issue

prostate-specific antigen PSA cancer test is an enzyme that breaks down peptide bonds. It’s produced by the prostate to liquefy semen, help sperm swim freely, and dissolve cervical mucus to allow sperm into the uterus.

Despite its name, prostate specific antigen psa test is also found in female ejaculate; for that matter, it shows up in the amniotic fluid and breast milk, albeit in smaller concentrations. It also appears in trace amounts in urethral glands, endometrium, breast tissue, and salivary gland tissue. Normally high amounts of PSA are often present in men with prostate cancer.

However, it should be noted that testing for prostate cancer by looking for high levels of PSA isn’t conclusive. Normal PSA levels naturally rise with age. Less life-threatening conditions like prostatitis and benign prostatic hyperplasia (BPH) can also increase PSA levels and urinary tract infections. Ironically, so can prostate biopsies and surgeries–which are respectively used to test for and treat prostate cancer.

Doctors need to exercise caution when deciding to conduct biopsies and surgeries, especially in light of both the possibility of overtreatment (treating tumors that aren’t life-threatening, thereby unnecessarily exposing the patient to harmful side effects of cancer treatment), and the high rate of false positives http://doi.org/10.1001/jama.2018.3710, page 1905, on this phrase> in the older adult population, who are at greater risk of these conditions to begin with. On the other hand, certain medications for BPH can lower PSA levels. For all these reasons and more (e.g., uncertainty regarding how PSA levels depend on ethnicity), there’s no clear consensus on what threshold level(s) of PSA should be considered “abnormal”.

A continuous rise in a man’s PSA levels over time may be a more reliable sign of prostate cancer (indeed, this test is used to detect the recurrence of prostate cancer after treatment). The rate of this rise (whether due to aging, cancer, or what have you) is called his “PSA velocity”.

Scientists are currently investigating the usefulness of other measurements as proxies for the presence of malignant prostate cancer. Examples include: the ratio of free PSA (not bound to other proteins in the blood) to total PSA–a lower ratio may be associated with more aggressive cancer;

the ratio of the blood level of PSA to the volume of the transition zone of the prostate (the portion of the prostate surrounding the urethra)–this accounts for PSA levels and prostate size, both of which are related to the presence or absence of cancer;

Age-specific reference ranges for PSA–these haven’t been favored because their use may delay legitimate diagnosis of prostate cancer; measurements of inactive precursors to PSA in conjunction with those of free and total PSA–creating a “prostate health index” of sorts, to help men decide whether to have a biopsy; measuring all different structural forms (isoforms) of PSA in the blood–this may improve the ability of doctors to recommend prostate cancer patients for biopsy; and tests that measure PSA in conjunction with other biomarkers linked to prostate cancer–this may help distinguish which cases are high-risk. <https://www.cancer.gov/types/prostate/psa-fact-sheet#how-are-researchers-trying-to-improve-the-psa-test>

PSA could be linked to several issues male patients have. This is why it’s so important to test PSA levels to gain clarity on these issues. Testing can be done quickly, accurately, and in-house with the use of PSA Plus slides for the FREND™ System [Learn more].